Northwestern University Feinberg School of Medicine
Skip to main content

Translational Research in Malignancy Members

The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.

Patel, Hiten

Patel, Hiten

Assistant Professor

Bio

Dr. Patel is a urologist specializing in urologic oncology. He is a clinical investigator focusing on improving the diagnosis and management of prostate cancer and kidney cancer. His prior work has fo... [more]

Patel, Jyoti D.

Bio

I am a medical oncologist with expertise in clinical and translational research in thoracic cancers and clinical drug development. I have led multiple clinical trials with novel drugs at all levels, f... [more]

Perlman, Elizabeth

Bio

Dr. Elizabeth Perlman is a clinician scientist whose predominant clinical role is to serve as the central pathology reviewer for the Children's Oncology Group Renal Tumor Committee. In this capac... [more]

Peter, Marcus

Bio

Dr. Peter has been working in the apoptosis and death receptor field for 19 years. His initial work in 1995 described the first multiprotein complex in apoptosis, the CD95 death-inducing signaling com... [more]

Plant, Ashley

Plant, Ashley

Associate Professor

Bio

My research is focused on understanding the immune microenvironment of pediatric brain tumors and the role of immunotherapy in the treatment of pediatric brain tumors.

Platanias, Leonidas C.

Bio

Dr. Platanias' laboratory is focused on studying abnormalities in signal transduction pathways in malignant myeloid cells. The ultimate goal of the work in Dr. Platanias' laboratory is to identify int... [more]

Pollack, Seth

Pollack, Seth

Associate Professor

Bio

The goal of my research is to cure patients with advanced sarcomas with immunotherapy. My research has mainly focused at targeting the immunogenic protein NY-ESO-1 which is highly expressed in certain... [more]